Lexpos News

/Lexpos News/

Just over a week left to submit valproate audit data

6,514 contractors have submitted their valproate audit data; have you submitted your data yet? By 31st March 2023, all community pharmacy contractors must have completed the 2022/23 national clinical audit on valproate over a six-week consecutive period and have submitted their data via the Valproate audit 2022/23 tab on MYS. This is a mandatory contractual [...]

The post Just over a week left to submit valproate audit data appeared first on PSNC Website.

By |March 22nd, 2023|Lexpos News|Comments Off on Just over a week left to submit valproate audit data

March 2023 Price Concessions 2nd Update

The Department of Health and Social Care (DHSC) has today (22/03/2023) granted the following list of price concessions for March 2023. Drug Pack size Price concession Bisoprolol 2.5mg tablets 28 £1.18 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment 30 £10.29 Clarithromycin 250mg/5ml oral suspension 70 £5.54 Clotrimazole 1% cream 20 £2.29 Co-codamol 30mg/500mg effervescent tablets 32 [...]

The post March 2023 Price Concessions 2nd Update appeared first on PSNC Website.

By |March 22nd, 2023|Lexpos News|Comments Off on March 2023 Price Concessions 2nd Update

PQS: NHSE publishes 2019/20 high risk audit report

NHS England (NHSE) has published a report on the high risk medicines audit* from the 2019/20 Pharmacy Quality Scheme (PQS). 10,673 (90%) community pharmacy contractors participated in the audit and 40,419 patients were audited. This audit shows that pharmacists and pharmacy teams have a very important role in ensuring that high risk medicines are understood [...]

The post PQS: NHSE publishes 2019/20 high risk audit report appeared first on PSNC Website.

By |March 21st, 2023|Lexpos News|Comments Off on PQS: NHSE publishes 2019/20 high risk audit report

MHRA Class 3 Medicines Recall: Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd)

Drug alert number: EL(23)A/11 Date issued: 21 March 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd) – PL 00427/0258 Batch Number Expiry Date Pack Size First Distributed SLD22002 April 2025 122ml June 2022 Active Pharmaceutical Ingredients: Sildenafil (as Citrate) [...]

The post MHRA Class 3 Medicines Recall: Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd) appeared first on PSNC Website.

By |March 21st, 2023|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd)

Peers hold parliamentary debate on community pharmacy

Community pharmacies received strong backing today in the House of Lords, with a number of Peers speaking out in support of pharmacies and others asking when Government would address the current crisis in the sector. The House of Lords oral questions session was opened by Baroness Hodgson on behalf of Baroness Cumberlege as follows: “To [...]

The post Peers hold parliamentary debate on community pharmacy appeared first on PSNC Website.

By |March 20th, 2023|Lexpos News|Comments Off on Peers hold parliamentary debate on community pharmacy